VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Friday, January 2, 2026
Stock Comparison
Johnson & Johnson vs KONE Oyj
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Johnson & Johnson
JNJ · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Johnson & Johnson's moat claims, evidence, and risks.
View JNJ analysisKONE Oyj
KNEBV · Nasdaq Helsinki
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: KONE Oyj leads (63 / 100 vs 61 / 100 for Johnson & Johnson).
- Segment focus: Johnson & Johnson has 2 segments (64.1% in Innovative Medicine); KONE Oyj has 3 segments (40.6% in New Building Solutions).
- Primary market structure: Competitive vs Oligopoly. Pricing power: Moderate vs Weak.
- Moat breadth: Johnson & Johnson has 5 moat types across 3 domains; KONE Oyj has 8 across 4.
Primary market context
Johnson & Johnson
Innovative Medicine
Branded prescription pharmaceuticals (biopharma)
Global
Wholesalers, hospitals, retailers, healthcare professionals, payers
Drug discovery, development, manufacturing, commercialization
64.1%
KONE Oyj
New Building Solutions
Elevator, escalator and automatic building door new equipment (new installations)
Global
Property developers and general contractors
OEM + project installation
40.6%
Side-by-side metrics
Moat coverage
Shared moat types
Johnson & Johnson strengths
KONE Oyj strengths
Segment mix
Johnson & Johnson segments
Full profile >Innovative Medicine
Competitive
MedTech
Oligopoly
KONE Oyj segments
Full profile >New Building Solutions
Oligopoly
Service (maintenance & repairs)
Competitive
Modernization
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.